Tsoukas, C., Gilbert, L., Lewis, T., Hatzakis, G., Falcon, R., & Mrus, J. (2013). Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. Hindawi Publishing Corporation.
Chicago Style aipamenaTsoukas, Christos, Louise Gilbert, Trevor Lewis, George Hatzakis, Ron Falcon, and Joseph Mrus. Improvements in Immune Function and Activation With 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. Hindawi Publishing Corporation, 2013.
MLA aipamenaTsoukas, Christos, et al. Improvements in Immune Function and Activation With 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. Hindawi Publishing Corporation, 2013.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.